跳至主要内容
临床试验/ITMCTR2000003455
ITMCTR2000003455尚未招募1 期

Efficacy and Safety of Shou-Zu-Ning Decoction in the Treatment of MKIs-induced grade III Hand-Foot Syndrome: a Prospective, Open, One-arm, Multi-Center Trial

The First Affiliated Hospital of Zhejiang Chinese Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • 1. Male or female patients aged > 18 years;
  • 2. Patients receiving MKIs for any malignancy;
  • 3. Grade III hand-foot syndrome according to NCI-CTC 5.0 standard;
  • 4. KPS > 60, life expectancy >=3 months; 5. The functional level of major organs met the following criteria:
  • 1) ANC (> 1.5 *10^9/L), PLT (> 80 *10^9/L), Hb (> 90 g/L);
  • 2) TBIL < 1.5 ULN, ALT, AST < 2.5 ULN, with liver metastasis < 5 ULN, BUN and Cr < 1 ULN or endogenous creatinine clearance (>50 ml/min) (Cockcroft-Gault formula);
  • 6. Signed informed consent.

排除标准

  • 1. Pre-existing dermopathy or drug allergy;
  • 2. Concomitant administration of drugs that can cause HFS eg capecitabine, docetaxel, liposomal doxorubicin, etc. in four weeks; 3. Uncontrolled infections and metabolic diseases;
  • 4. Coagulation disorders, known bleeding tendency or thrombophilia;
  • 5. The investigators consider the patients are not suitable for this trial.

研究者

发起方
The First Affiliated Hospital of Zhejiang Chinese Medical University

相似试验